Loading...
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel
Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a rapid increase in the use of coronary intervention procedures. Clopidogrel is the thienopyridine of choice for dual antiplatelet therapy in patients treated with percutaneous coronary intervention. However, there are two is...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686264/ https://ncbi.nlm.nih.gov/pubmed/19475783 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|